Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
出版年份 2018 全文链接
标题
Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
作者
关键词
-
出版物
Nutrients
Volume 10, Issue 6, Pages 731
出版商
MDPI AG
发表日期
2018-06-06
DOI
10.3390/nu10060731
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combination Therapies Targeting HDAC and IKK in Solid Tumors
- (2018) Ivana Vancurova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Renoprotective effect of cinnamaldehyde in food color induced toxicity
- (2018) Uma Kant Sharma et al. 3 Biotech
- Renoprotective effect of cinnamaldehyde in food color induced toxicity
- (2018) Uma Kant Sharma et al. 3 Biotech
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Medicinal attributes of major phenylpropanoids present in cinnamon
- (2016) Uma Kant Sharma et al. BMC Complementary and Alternative Medicine
- Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation
- (2016) Lianmin Bao et al. CELL BIOLOGY AND TOXICOLOGY
- Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer
- (2016) Hélène Losson et al. MOLECULES
- HDAC inhibitors in solid tumors and blood cancers
- (2016) Leslie K. Ferrarelli Science Signaling
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- HDAC inhibitors in solid tumors and blood cancers
- (2016) Leslie K. Ferrarelli Science Signaling
- Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways
- (2015) Jianbin Zhang et al. Autophagy
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Aceroside VIII is a New Natural Selective HDAC6 Inhibitor that Synergistically Enhances the Anticancer Activity of HDAC Inhibitor in HT29 Cells
- (2015) Hyun-Wook Ryu et al. PLANTA MEDICA
- Protective Effect of Bauhinia variegata Leaf Extracts Against Oxidative Damage, Cell Proliferation and Bacterial Growth
- (2015) Amit Kumar Sharma et al. Proceedings of the National Academy of Sciences, India. Section B
- Histone deacetylase 6 in health and disease
- (2015) Carole Seidel et al. Epigenomics
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
- (2014) Shalome Bassett et al. Nutrients
- In VitroAntibacterial, Antioxidant, and Cytotoxic Activities ofParthenium hysterophorusand Characterization of Extracts by LC-MS Analysis
- (2014) Shashank Kumar et al. Biomed Research International
- Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer
- (2014) Channing J. Paller et al. Cancer Medicine
- Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair
- (2014) Kelly E. Johnson et al. Advances in Wound Care
- The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
- (2014) Dineo Khabele Frontiers in Oncology
- Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
- (2013) Ming-Tsang Chiao et al. Autophagy
- A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
- (2013) F. Santoro et al. BLOOD
- Histone deacetylase (HDAC) inhibitory and antiproliferative activities of phenolic-rich extracts derived from the rhizome of Hydnophytum formicarum Jack.: sinapinic acid acts as HDAC inhibitor
- (2013) Thanaset Senawong et al. BMC Complementary and Alternative Medicine
- Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy
- (2013) L. Shulak et al. JOURNAL OF VIROLOGY
- Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
- (2013) Sascha Venturelli et al. PLoS One
- Chemistry and Biological Activities of Flavonoids: An Overview
- (2013) Shashank Kumar et al. TheScientificWorldJOURNAL
- Green tea and the risk of gastric cancer: Epidemiological evidence
- (2013) I-Chun Hou WORLD JOURNAL OF GASTROENTEROLOGY
- Parthenium hysterophorus:A Probable Source of Anticancer, Antioxidant and Anti-HIV Agents
- (2013) Shashank Kumar et al. Biomed Research International
- Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer
- (2012) Carola Parolin et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition
- (2012) Lv Li et al. Cancer Cell International
- Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas
- (2012) Mei Dong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
- (2012) U. Banerji et al. CLINICAL CANCER RESEARCH
- Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial
- (2012) Madeleine Duvic et al. EUROPEAN JOURNAL OF CANCER
- Histone deacetylase modulators provided by Mother Nature
- (2012) Carole Seidel et al. Genes and Nutrition
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases
- (2012) Alexander Berger et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- Phytochemicals and Cancer Risk
- (2012) Paige E. Miller et al. NUTRITION IN CLINICAL PRACTICE
- Histone Deacetylase in Chronic Lymphocytic Leukemia
- (2012) J.C. Wang et al. ONCOLOGY
- Natural chalcones as dual inhibitors of HDACs and NF-κB
- (2012) B. ORLIKOVA et al. ONCOLOGY REPORTS
- Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
- (2012) Androniki Kretsovali et al. Stem Cells International
- Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
- (2011) A R A Razak et al. BRITISH JOURNAL OF CANCER
- Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
- (2011) R Pili et al. BRITISH JOURNAL OF CANCER
- HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
- (2011) Hao Geng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylases 9 and 10 Are Required for Homologous Recombination
- (2011) Shweta Kotian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors
- (2011) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
- (2011) Anas Younes et al. LANCET ONCOLOGY
- Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms
- (2011) Vibe Skov et al. LEUKEMIA & LYMPHOMA
- SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production
- (2011) E L Bell et al. ONCOGENE
- Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
- (2010) Yuan-Ling Liu et al. Autophagy
- Inhibitors to understand molecular mechanisms of NAD+-dependent deacetylases (sirtuins)
- (2010) Michael Lawson et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
- (2010) Alessandro Rambaldi et al. BRITISH JOURNAL OF HAEMATOLOGY
- research paper: Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia
- (2010) Daniel Antunes Moreno et al. BRITISH JOURNAL OF HAEMATOLOGY
- HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth
- (2010) T. Milde et al. CLINICAL CANCER RESEARCH
- Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells
- (2010) Ju-Hee Lee et al. MOLECULES AND CELLS
- Histone Deacetylase Inhibitors in Cancer Therapy
- (2009) Andrew A. Lane et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of histone deacetylase1 induces autophagy
- (2008) Meeyeon Oh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
- (2008) Jung-Hyun Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo
- (2008) W. Weichert et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition
- (2008) Bin Shan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway
- (2008) A Hrzenjak et al. JOURNAL OF PATHOLOGY
- Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis
- (2008) Wilko Weichert et al. LANCET ONCOLOGY
- HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
- (2008) Andrew J. Wilson et al. MOLECULAR BIOLOGY OF THE CELL
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- Enantioselective Total Synthesis of (+)-Largazole, a Potent Inhibitor of Histone Deacetylase†
- (2008) Arun K. Ghosh et al. ORGANIC LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now